Table 3 Comparison of age, sex, body weight, and the results of laboratory tests between survivor and non-survivor groups

Age, median (years)

12.1 (n = 41, 10.7-13.5)

12.8 (n = 25, 10.1-15.3)

0.38

 Male

n = 22

n = 17

0.30

 Female

n = 20

n = 8

B.W. (kg)

3.8 (n = 42, 2.7-6.5)

5.3 (n = 25, 3.2-8.1)

0.15

Neu (/μL)

4,300–9,100

 0 hour

11,800 (n = 41, 8,200-17,200)

16,400 (n = 25, 10,600-19,300)

0.12

 24 hour

12,800 (n = 38, 9,225-16,800)

17,950 (n = 20, 13,750-22,550)

0.01

Lym (/μL)

2,000–4,600

 0 hour

2,000 (n = 41, 1,500-3,100)

3,000 (n = 25, 1,700-4,800)

0.11

 24 hour

1,950 (n = 38, 1,300-3,150)

2,200 (n = 20, 1,650-4,525)

0.14

Glu (mg/dL)

75.0–128.0

 0 hour

100.5 (n = 42, 91.8-118.0)

109.0 (n = 24, 86.3-136.0)

0.84

 24 hour

108.0 (n = 35, 97.5-116.5)

120.5 (n = 20, 100.3-160.3)

0.53

CRP (mg/dL)

0–1.0

 0 hour

7.4 (n = 37, 2.7-17.1)

9.8 (n = 23, 2.6-17)

0.84

 24 hour

8.4 (n = 25, 4.5-14.1)

16.5 (n = 12, 8.4-19.1)

0.31

SCC (μg/dL)

1.0–6.0

 0 hour

7.5 (n = 42, 4.6-18.3)

12.1 (n = 25, 6.3-22.9)

0.20

 24 hour

4.8 (n = 42, 3.7-8.6)

8.8 (n = 20, 7.1-15.8)

< 0.001

Inc SCC (μg/dL)

-2.9 (n = 42, -10.6-0)

-0.25 (n=20, -5.8-1.5)

0.02

R Inc SCC (%)

0.51 (n = 42, 0.34-1)

0.99 (n = 20, 0.57-1.2)

< 0.001